​

Funding Round

Venture Round - Lucy Therapeutics

Venture Round - Lucy Therapeutics

Investment Firm

Overview

Lucy Therapeutics develops treatments for mitochondrial diseases and neurodegenerative disorders by targeting mitochondrial proteins.

Announced Date

May 28, 2024

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

Safar Partners

Safar Partners

Safar Partners is a early_stage_venture and late_stage_venture and seed and venture firm.

Engine Ventures

Engine Ventures

No designation

Participant Investors

3

Investor Name
Participant InvestorEngine Ventures
Participant InvestorSafar Partners
Participant InvestorBill Gates

Round Details and Background

Lucy Therapeutics raised $12500000 on 2024-05-28 in Venture Round

Lucy Therapeutics develops treatments for mitochondrial diseases and neurodegenerative disorders by targeting mitochondrial proteins.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 11, 2022
Grant - Lucy Therapeutics
1-4.9M
Oct 11, 2023
Grant - Lucy Therapeutics
1-undefined
May 28, 2024
Venture Round - Lucy Therapeutics
4-12.5M
May 28, 2024
Grant - Lucy Therapeutics
1-2.0M

Recent Activity

There is no recent news or activity for this profile.